The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol. 2016;22(3):319-326.   Published online 2016 Sep 25     DOI: https://doi.org/10.3350/cmh.2016.0045
Citations to this article as recorded by Crossref logo
Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients
Lung-Yi Mak, Michael Ko, Elvis To, Danny Ka-Ho Wong, Justin Hei-Chun Ma, Teresa Lok-Yee Hui, Wai-Kay Seto, James Fung, Ching-Lung Lai, Man-Fung Yuen
Journal of Gastroenterology and Hepatology.2019;[Epub]     CrossRef
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B
Jonggi Choi, Hyo Jeong Kim, Jayoun Lee, Songhee Cho, Min Jung Ko, Young-Suk Lim
JAMA Oncology.2019; 5(1): 30.     CrossRef
Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients
Lung-Yi Mak, Wai-Pan To, Danny Ka-Ho Wong, James Fung, Fen Liu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen
World Journal of Gastroenterology.2019; 25(11): 1398.     CrossRef
Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013
Meredith S. Shiels, Eric A. Engels, Elizabeth L. Yanik, Katherine A. McGlynn, Ruth M. Pfeiffer, Thomas R. O’Brien
Cancer.2019;[Epub]     CrossRef
Infection par le virus de l’hépatite B : histoire naturelle, manifestations cliniques et principes thérapeutiques
O. Paccoud, L. Surgers, K. Lacombe
La Revue de Médecine Interne.2019; 40(9): 590.     CrossRef
Updates on Chronic HBV: Current Challenges and Future Goals
Hannah M. Lee, Bubu A. Banini
Current Treatment Options in Gastroenterology.2019; 17(2): 271.     CrossRef
High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young-Suk Lim
Alimentary Pharmacology & Therapeutics.2019; 50(2): 215.     CrossRef
Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepati
Xiaojuan Wu, Bei Cai, Zhenzhen Su, Yamei Li, Jin Xu, Rong Deng, Lanlan Wang
Journal of Clinical Laboratory Analysis.2018; 32(4): e22341.     CrossRef
Practical guidelines for performing laparoscopic liver resection based on the second international laparoscopic liver consensus conference
Jai Young Cho, Ho-Seong Han, Go Wakabayashi, Olivier Soubrane, David Geller, Nicholas O'Rourke, Joseph Buell, Daniel Cherqui
Surgical Oncology.2018; 27(1): A5.     CrossRef
Clinical states of cirrhosis and competing risks
Gennaro D'Amico, Alberto Morabito, Mario D'Amico, Linda Pasta, Giuseppe Malizia, Paola Rebora, Maria Grazia Valsecchi
Journal of Hepatology.2018; 68(3): 563.     CrossRef
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim
Gut and Liver.2018; 12(2): 190.     CrossRef
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee
Gut.2018; 67(5): 945.     CrossRef
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher, Valérie Vilgrain
Journal of Hepatology.2018; 69(1): 182.     CrossRef
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia
World Journal of Gastroenterology.2018; 24(17): 1825.     CrossRef
Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir
Jung Woo Shin, Seok Won Jung, Seung Bum Lee, Byung Uk Lee, Bo Ryung Park, Eun Ji Park, Neung Hwa Park
American Journal of Gastroenterology.2018; 113(7): 998.     CrossRef
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang
American Society of Clinical Oncology Educational Book.2018; (38): 262.     CrossRef
Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment
Nam Hee Kim, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim
Digestive Diseases and Sciences.2018; 63(10): 2792.     CrossRef
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir
Hung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Cheng-Yuan Peng, Chien-Hung Chen
Liver International.2018; 38(11): 1997.     CrossRef
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447.     CrossRef
Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
Sung Won Chung, Young Chang, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke
Journal of Hepatology.2017; 67(2): 370.     CrossRef
Detection of HBV Covalently Closed Circular DNA
Xiaoling Li, Jinghua Zhao, Quan Yuan, Ningshao Xia
Viruses.2017; 9(6): 139.     CrossRef
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
Yong Eun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Sojung Han, Mi Young Jeon, Ja Yoon Heo, Kijun Song, Seung Up Kim
Journal of Gastroenterology and Hepatology.2017; 32(6): 1221.     CrossRef
Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2/STAT3 signaling pathway
Shaofang Chen, Zhanglin Wang, Shichuan Wan, Hai Huang, Huiqing Liang
Molecular Medicine Reports.2017; 16(5): 7416.     CrossRef